Pharmaceutical Sciences


Repurposing of Colchicine for COVID-19 treatment


Life Sciences & Biotechnology, Pharmaceutical Sciences, COVID-19 Technology

Focus Area:

Development of Repurposed Drugs for COVID-19

Company Transferred:

Laxai Life Sciences, Hyderabad

Developing Agency:

Indian Institute of Integrative Medicine (CSIR-IIIM), Jammu; Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad
Website Link :;

Brief Description

Description :

This is a FDA approved drug for gout. Tablets are available with the Cadila. The same dose of tablets (0.5 mg) is propsoed to be used for COVID-19 trial. The clinical trial strategy for conducting Phase II clinical trial of colchicine along with a comparative arm of SoC, has been prepared.

Related Technologies